An analysis of malarial parasitaemia, splenomegaly, antimalarial antibodies, immunoglobulin levels, and reticuloendothelial phagocytic function was undertaken in patients with Burkitt's lymphoma in Uganda. The results reveal no difference between the Burkitt patients and controls, with the exception of lower IgM levels among the lymphoma patients. This study provides partial support for the epidemiological evidence incriminating malaria as a co-factor in the aetiology of Burkitt's lymphoma.